V-103

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameV-103
Drug Alias Nameperi-procedural bruising therapy (Vicept)V-103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor modulators
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsContusions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVicept Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan IncVicept Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsContusions

Other Information

ATC CodeN/A
Related LinksN/A